Jason Lettmann

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: ALX Oncology Holdings Inc., 3 years.

ALX Oncology Holdings Inc. Director · CHIEF EXECUTIVE OFFICER
3 years · Since 2023

Chief executive roles

ALX Oncology Holdings Inc. · Chief Executive Officer
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 17, 2026 ALX Oncology Holdings Inc. Open-market sale −2,230 $1.93 $4,304
Mar 19, 2026 ALX Oncology Holdings Inc. Open-market sale −12,311 $2.17 $26,715
Feb 17, 2026 ALX Oncology Holdings Inc. Shares withheld for tax −2,201 $2.27 $4,996
Sep 17, 2025 ALX Oncology Holdings Inc. Open-market purchase +71,163 $1.08 $76,856
Sep 16, 2025 ALX Oncology Holdings Inc. Open-market purchase +21,070 $1.07 $22,545
Aug 15, 2025 ALX Oncology Holdings Inc. Open-market sale −2,382 $0.64 $1,524
Mar 14, 2025 ALX Oncology Holdings Inc. Grant or award +42,000 — —
Feb 19, 2025 ALX Oncology Holdings Inc. Open-market sale −2,159 $1.15 $2,483
Aug 14, 2024 ALX Oncology Holdings Inc. Shares withheld for tax −2,191 $2.58 $5,653
Mar 14, 2024 ALX Oncology Holdings Inc. Open-market purchase +4,400 $11.31 $49,764
Feb 14, 2024 ALX Oncology Holdings Inc. Grant or award +60,000 — —

Questions about Jason Lettmann

What boards is Jason Lettmann on?

Jason Lettmann sits on the board of ALX Oncology Holdings Inc.

What company is Jason Lettmann the CEO of?

Jason Lettmann is Chief Executive Officer of ALX Oncology Holdings Inc.

How long has Jason Lettmann served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.